{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T15:07:39Z","timestamp":1779030459023,"version":"3.51.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to develop a highly sensitive and specific liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) method for the simultaneous determination of propranolol and its metabolites in human biological samples. By analyzing their presence in urine, postmortem biological fluids, and various solid tissues, the study could be of reliable forensic toxicological use for investigations in propranolol poisoning cases. In this study, the Standard Addition Method (SAM) was used for quantification, and its validation was mixed with one of the analyte\u2019s concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 0.1\u2009mL aliquot of each body fluid sample or 0.1\u2009g each of homogenized solid tissue was mixed with one of the analyte concentration standards, extracted with methanol, spiked with an internal standard (IS) using the SAM, and purified using magnesium sulfate and sodium sulfate. Following centrifugation and filtration, samples were analyzed via LC\u2013MS\/MS. Samples underwent enzymatic hydrolysis to quantify total metabolite concentrations (free plus conjugated) prior to analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Phase I metabolites (propranolol, 4-hydroxypropranolol, propranolol glycol, N-desisopropylpropranolol, 1-naphthylenyloxyacetic acid, and 1-naphthol) and phase II metabolites (sulfate and glucuronide conjugates) were identified in urine. Among postmortem samples, propranolol was highest in the bile, followed by the lung tissue. Naphthoxylactic acid could be consistently detected in all samples except for the brain, suggesting its potential as a good biomarker for propranolol exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A validated LC\u2013MS\/MS method for determining propranolol and its metabolites in forensic samples was established, and it could also be applied to the authentic human samples obtained from a propranolol poisoning case. The findings could offer substantial and reliable support for investigating propranolol-related fatalities and contribute to the comprehensive understanding of the metabolism of propranolol in the human body.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jat\/bkaf107","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:56:00Z","timestamp":1765976160000},"source":"Crossref","is-referenced-by-count":1,"title":["Analysis of propranolol and its metabolites in postmortem human solid tissues and body fluids: LC\u2013MS\/MS approach with the standard addition method applied to a forensic case"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4957-0172","authenticated-orcid":false,"given":"Mengchao","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3626-4029","authenticated-orcid":false,"given":"Xiaolong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqin","family":"Sun","sequence":"additional","affiliation":[{"name":"Affiliated Cancer Hospital of Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlei","family":"Liu","sequence":"additional","affiliation":[{"name":"Criminal Science and Technology Office, Public Security Bureau , Qingshuihe County, Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wurita","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, College of Basic Medical Sciences, Inner Mongolia Medical University , Hohhot,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-3949","authenticated-orcid":false,"given":"Koutaro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, Hamamatsu University School of Medicine , Higashi-ku, Hamamatsu 431-3192,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2026051710452848100_bkaf107-B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/aian.AIAN_201_18","article-title":"Propranolol: A 50-year historical perspective","volume":"22","author":"Srinivasan","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"2026051710452848100_bkaf107-B2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/0002-8703(73)90139-7","article-title":"Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program","volume":"86","author":"Greenblatt","year":"1973","journal-title":"Am Heart J"},{"key":"2026051710452848100_bkaf107-B3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/bs.podrm.2017.02.006","volume-title":"Profiles of Drug Substances, Excipients and Related Methodology","author":"Al-Majed","year":"2017"},{"key":"2026051710452848100_bkaf107-B4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cpt1970111112","article-title":"Plasma propranolol levels in adults with observations in four children","volume":"11","author":"Shand","year":"1970","journal-title":"Clin Pharmacol Ther"},{"key":"2026051710452848100_bkaf107-B5","doi-asserted-by":"publisher","first-page":"110978","DOI":"10.1016\/j.forsciint.2021.110978","article-title":"Propranolol and metoprolol: Two comparable drugs with very different post-mortem toxicological profiles","volume":"327","author":"Kriikku","year":"2021","journal-title":"Forensic Sci Int"},{"key":"2026051710452848100_bkaf107-B6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0022-3565(25)28787-0","article-title":"Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey","volume":"176","author":"Hayes","year":"1971","journal-title":"J Pharmacol Exp Ther"},{"key":"2026051710452848100_bkaf107-B7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-3565(25)29253-9","article-title":"Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites","volume":"182","author":"Walle","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"2026051710452848100_bkaf107-B8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0090-9556(25)08146-2","article-title":"Quantitative account of propranolol metabolism in urine of normal man","volume":"13","author":"Walle","year":"1985","journal-title":"Drug Metab Dispos"},{"key":"2026051710452848100_bkaf107-B9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0378-4347(00)82062-9","article-title":"Determination of propranolol and six metabolites in human urine by high-pressure liquid chromatography","volume":"162","author":"Pritchard","year":"1979","journal-title":"J Chromatogr"},{"key":"2026051710452848100_bkaf107-B10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpba.2009.06.050","article-title":"Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography\/electrospray tandem mass spectrometry","volume":"50","author":"Partani","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"2026051710452848100_bkaf107-B11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11419-015-0303-8","article-title":"Postmortem redistribution of methamphetamine and amphetamine in blood specimens from various blood vessels and in the specimens from pericardial fluid, bile, stomach contents and various solid tissues collected from a human cadaver","volume":"34","author":"Wurita","year":"2016","journal-title":"Forensic Toxicol"},{"key":"2026051710452848100_bkaf107-B12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11419-021-00585-8","article-title":"The standard addition method and its validation in forensic toxicology","volume":"39","author":"Hasegawa","year":"2021","journal-title":"Forensic Toxicol"},{"key":"2026051710452848100_bkaf107-B13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF00928167","article-title":"Of pigs and men and research: A review of applications and analogies of the pig, sus scrofa, in human medical research","volume":"3","author":"Douglas","year":"1972","journal-title":"Space Life Sci"},{"key":"2026051710452848100_bkaf107-B14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0090-9556(25)08435-1","article-title":"Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase","volume":"22","author":"Masubuchi","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"2026051710452848100_bkaf107-B15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/bdd.2510050208","article-title":"Biliary excretion and enterohepatic circulation of two beta-adrenergic blocking drugs, exaprolol and propranolol in rats","volume":"5","author":"Tom\u010d\u00edkov\u00e1","year":"1984","journal-title":"Biopharm Drug Disp"},{"key":"2026051710452848100_bkaf107-B16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000137373","article-title":"Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage","volume":"20","author":"Kornhauser","year":"1980","journal-title":"Pharmacology"},{"key":"2026051710452848100_bkaf107-B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijpharm.2007.07.019","article-title":"Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans","volume":"349","author":"Kiriyama","year":"2008","journal-title":"Int J Pharm"},{"key":"2026051710452848100_bkaf107-B18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jps.2600710623","article-title":"Stereoselective disposition and glucuronidation of propranolol in humans","volume":"71","author":"Silber","year":"1982","journal-title":"J Pharm Sci"},{"key":"2026051710452848100_bkaf107-B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00420338","article-title":"The pharmacodynamics and metabolism of propranolol in man","volume":"2","author":"PAterson","year":"1970","journal-title":"Pharmacol Clin"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaf107\/66033415\/bkaf107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/3\/bkaf107\/68302852\/bkaf107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/3\/bkaf107\/68302852\/bkaf107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:45:34Z","timestamp":1779029134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkaf107\/8384256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaf107","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,12,19]]},"article-number":"bkaf107"}}